# Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study

> **NCT01764490** · — · COMPLETED · sponsor: **JESUS RODRIGUEZ BAÑO** · enrollment: 1344 (actual)

## Conditions studied

- Clinically Significant Bacteremia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01764490
- **Lead sponsor:** JESUS RODRIGUEZ BAÑO
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-12
- **Final completion:** 2014-05
- **Target enrollment:** 1344 (ACTUAL)
- **Last updated:** 2014-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01764490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01764490, "Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01764490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*